Celyad Oncology SA (EBR:CYAD)
Belgium flag Belgium · Delayed Price · Currency is EUR
0.4600
-0.0200 (-4.17%)
May 15, 2025, 11:15 AM CET

Celyad Oncology Market Cap

Celyad Oncology has a market cap or net worth of €19.22 million as of May 16, 2025. Its market cap has increased by 52.88% in one year.

Market Cap
19.22M
Enterprise Value
15.93M
Revenue
186.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.46

Market Cap Chart

Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 19.22M, a decrease of -81.15%. That is a compound annual growth rate of -13.11%.

History

DateMarket Cap% Change
May 15, 202519.22M-34.83%
Dec 31, 202429.50M82.56%
Dec 29, 202316.16M41.33%
Dec 30, 202211.43M-85.60%
Dec 31, 202179.42M-13.96%
Dec 31, 202092.30M-31.75%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
argenx SE 29.66B
UCB SA 29.36B
Financière de Tubize 5.45B
Fagron NV 1.55B
Ion Beam Applications 335.65M
Nyxoah 200.24M
Onward Medical 188.85M
Hyloris Pharmaceuticals 169.68M
Market Cap Rankings